Shuai Lin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Breast Reconstruction

Bioinformatics Analysis

Coronary Artery Bypass

Top Venues

Cancer medicine

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Peng Xu, Wen Luo, Jingjing Hu, Xiaobin Ma, Qian Hao, Wentao Hui, Zhangjian Zhou, Shuai Lin, Meng Wang, Hao Wu, Zhi-Jun Dai, Huafeng Kang
Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016). Cancer medicine 13 (11) (2024)
Peng Xu, Wen Luo, Jingjing Hu, Xiaobin Ma, Qian Hao, Wentao Hui, Zhangjian Zhou, Shuai Lin, Meng Wang, Hao Wu, Zhi-Jun Dai, Huafeng Kang
Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016). Cancer medicine 13 (11) (2024)
Xueting Ren, Hanxiao Cui, Jianhua Wu, Ruina Zhou, Nan Wang, Dandan Liu, Xin Xie, Hao Zhang, Di Liu, Xiaobin Ma, Chengxue Dang, Huafeng Kang, Shuai Lin
Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Cancer medicine 11 (20) (2022)
Luyao Dai, Hanxiao Cui, Yuanhang Bao, Liqun Hu, Zhangjian Zhou, Meng Wang, Shuai Lin, Hao Wu, Huafeng Kang, Xiaobin Ma
The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer. Cancer medicine (2022)
Shuai Lin, Yi Zheng, Meng Wang, Linghui Zhou, Yuyao Zhu, Yujiao Deng, Ying Wu, Dai Zhang, Na Li, Huafeng Kang, Zhijun Dai
Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study. Molecular biology reports 49 (3) (2022)